News9 new results for pharmaceutical news Lupin aims to double sales in Japan to $500 million in next 5 yearsEconomic TimesThe Mumbai-headquartered firm, which is present in Japan through two wholly-owned subsidiaries -- Kyowa Pharmaceutical Industry and I'rom Pharmaceuticals -- is aiming sales of $250 million (over Rs 1,300 crore) from the country this fiscal. In order to ...See all stories on this topic »New drug pricing policy may impact MNCs most: AnalystsEconomic TimesStill a market-based policy is a balanced formula and will help improve the availability of essential medicines for patients," Organisation of Pharmaceutical Producers of India (OPPI) president and Novartis India vice-chairman and managing director ...See all stories...